Moving on after a stellar three years at Bayer AG, Marianne De Backer had plenty of CEO job offers but the lure of returning to the infectious disease space to lead Vir Biotechnology, Inc. proved too strong to resist.
At the end of January, De Backer was unveiled as the successor to biotech industry veteran George Scangos at Vir,...





